Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).
2017
We report the discovery and
medicinal chemistryoptimization of a novel series of pyrazole-based inhibitors of human lactate dehydrogenase (LDH). Utilization of a quantitative
high-throughput screeningparadigm facilitated hit identification, while structure-based design and multiparameter optimization enabled the development of compounds with potent enzymatic and cell-based inhibition of LDH enzymatic activity.
Lead compoundssuch as 63 exhibit low nM inhibition of both LDHA and LDHB, submicromolar inhibition of lactate production, and inhibition of glycolysis in MiaPaCa2 pancreatic cancer and A673 sarcoma cells. Moreover, robust target engagement of LDHA by
lead compoundswas demonstrated using the cellular
thermal shift assay(CETSA), and drug–target
residence timewas determined via SPR. Analysis of these data suggests that drug–target
residence time(off-rate) may be an important attribute to consider for obtaining potent cell-based inhibition of this cancer metabolism target.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
49
References
62
Citations
NaN
KQI